Advertisement
Screener

HENRY SCHEIN, INC. (HSIC) Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest

HENRY SCHEIN, INC. Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest

HENRY SCHEIN, INC. (HSIC) reported Net Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest of $101.00 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-04.

Financial Statements › Shareholders' Equity

us-gaap:NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest · last filed 2026-08-04

  • HENRY SCHEIN, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-06-27 was $101.00M, a 8.60% increase year-over-year.
  • HENRY SCHEIN, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2026-03-28 was $113.00M, a 1.74% decline year-over-year.
  • HENRY SCHEIN, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-12-27 was $108.00M, a 11.34% increase year-over-year.
  • HENRY SCHEIN, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for the quarter ending 2025-09-27 was $108.00M, a 10.20% increase year-over-year.
  • HENRY SCHEIN, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2025 was $424.00M, a 6.27% increase from fiscal 2024.
  • HENRY SCHEIN, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2024 was $399.00M, a 7.21% decline from fiscal 2023.
  • HENRY SCHEIN, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2023 was $430.00M, a 21.10% decline from fiscal 2022.
  • HENRY SCHEIN, INC. net income (loss), including portion attributable to nonredeemable noncontrolling interest for fiscal 2022 was $545.00M, a 14.44% decline from fiscal 2021.
Period endNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 3 month as first filedNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 6 month as first filedNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 9 month as first filedNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 monthNet Income (Loss), Including Portion Attributable to Nonredeemable Noncontrolling Interest 12 month as first filed
2026-06-27$101.00M
10-Q · filed 2026-08-04
$214.00M
10-Q · filed 2026-08-04
$322.00M
derived: sum of 3 quarters · filed 2026-08-04
$430.00M
derived: sum of 4 quarters · filed 2026-08-04
2026-03-28$113.00M
10-Q · filed 2026-05-05
$221.00M
derived: sum of 2 quarters · filed 2026-05-05
$329.00M
derived: sum of 3 quarters · filed 2026-05-05
$422.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-12-27$108.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$216.00M
derived: sum of 2 quarters · filed 2026-02-24
$309.00M
derived: sum of 3 quarters · filed 2026-08-04
$424.00M
10-K · filed 2026-02-24
2025-09-27$108.00M
10-Q · filed 2025-11-04
$201.00M
derived: sum of 2 quarters · filed 2026-08-04
$316.00M
10-Q · filed 2025-11-04
$413.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-06-28$93.00M
10-Q · filed 2026-08-04
$208.00M
10-Q · filed 2026-08-04
$305.00M
derived: sum of 3 quarters · filed 2026-08-04
$403.00M
derived: sum of 4 quarters · filed 2026-08-04
2025-03-29$115.00M
10-Q · filed 2026-05-05
$212.00M
derived: sum of 2 quarters · filed 2026-05-05
$310.00M
derived: sum of 3 quarters · filed 2026-05-05
$418.00M
derived: sum of 4 quarters · filed 2026-05-05
2024-12-28$97.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$195.00M
derived: sum of 2 quarters · filed 2026-02-24
$303.00M
derived: sum of 3 quarters · filed 2026-02-24
$399.00M
10-K · filed 2026-02-24
2024-09-28$98.00M
10-Q · filed 2025-11-04
$206.00M
derived: sum of 2 quarters · filed 2025-11-04
$302.00M
10-Q · filed 2025-11-04
$324.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-06-29$108.00M
10-Q · filed 2025-08-05
$204.00M
10-Q · filed 2025-08-05
$226.00M
derived: sum of 3 quarters · filed 2026-02-24
$367.00M
derived: sum of 4 quarters · filed 2026-02-24
2024-03-30$96.00M
10-Q · filed 2025-05-05
$118.00M
derived: sum of 2 quarters · filed 2026-02-24
$259.00M
derived: sum of 3 quarters · filed 2026-02-24
$402.00M
derived: sum of 4 quarters · filed 2026-02-24
2023-12-30$22.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24
$163.00M
derived: sum of 2 quarters · filed 2026-02-24
$306.00M
derived: sum of 3 quarters · filed 2026-02-24
$430.00M
10-K · filed 2026-02-24
2023-09-30$141.00M
10-Q · filed 2024-11-05
$284.00M
derived: sum of 2 quarters · filed 2024-11-05
$408.00M
10-Q · filed 2024-11-05
$457.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-07-01$143.00M
10-Q · filed 2024-08-06
$267.00M
10-Q · filed 2024-08-06
$316.00M
derived: sum of 3 quarters · filed 2025-02-25
$468.00M
derived: sum of 4 quarters · filed 2025-02-25
2023-04-01$124.00M
10-Q · filed 2024-05-07
$173.00M
derived: sum of 2 quarters · filed 2025-02-25
$325.00M
derived: sum of 3 quarters · filed 2025-02-25
$487.00M
derived: sum of 4 quarters · filed 2025-02-25
2022-12-31$49.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25
$201.00M
derived: sum of 2 quarters · filed 2025-02-25
$363.00M
derived: sum of 3 quarters · filed 2025-02-25
$545.00M
10-K · filed 2025-02-25
2022-09-24$152.00M
10-Q · filed 2023-11-28
$314.00M
derived: sum of 2 quarters · filed 2023-11-28
$496.00M
10-Q · filed 2023-11-28
$644.00M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-25$162.00M
10-Q · filed 2023-08-07
$344.00M
10-Q · filed 2023-08-07
$492.00M
derived: sum of 3 quarters · filed 2024-02-28
$656.00M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-26$182.00M
10-Q · filed 2023-05-09
$330.00M
derived: sum of 2 quarters · filed 2024-02-28
$494.00M
derived: sum of 3 quarters · filed 2024-02-28
$651.00M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-25$148.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$312.00M
derived: sum of 2 quarters · filed 2024-02-28
$469.00M
derived: sum of 3 quarters · filed 2024-02-28
$637.00M
10-K · filed 2024-02-28
2021-09-25$164.00M
10-Q · filed 2022-11-01
$163.74M
10-Q · filed 2021-11-02
$321.00M
derived: sum of 2 quarters · filed 2022-11-01
$489.00M
10-Q · filed 2022-11-01
$488.61M
10-Q · filed 2021-11-02
$630.17M
derived: sum of 4 quarters · filed 2023-02-21
2021-06-26$157.00M
10-Q · filed 2022-08-02
$157.00M
10-Q · filed 2021-08-03
$325.00M
10-Q · filed 2022-08-02
$324.87M
10-Q · filed 2021-08-03
$466.17M
derived: sum of 3 quarters · filed 2023-02-21
$611.86M
derived: sum of 4 quarters · filed 2023-02-21
2021-03-27$168.00M
10-Q · filed 2022-05-03
$167.88M
10-Q · filed 2021-05-04
$309.17M
derived: sum of 2 quarters · filed 2023-02-21
$454.86M
derived: sum of 3 quarters · filed 2023-02-21
$443.27M
derived: sum of 4 quarters · filed 2023-02-21
2020-12-26$141.17M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-21
$286.86M
derived: sum of 2 quarters · filed 2023-02-21
$275.27M
derived: sum of 3 quarters · filed 2023-02-21
$406.00M
10-K · filed 2023-02-21
$406.06M
10-K · filed 2021-02-17
2020-09-26$145.69M
10-Q · filed 2021-11-02
$134.10M
derived: sum of 2 quarters · filed 2021-11-02
$264.83M
10-Q · filed 2021-11-02
$597.05M
derived: sum of 4 quarters · filed 2022-02-15
2020-06-27-$11.59M
10-Q · filed 2021-08-03
$119.14M
10-Q · filed 2021-08-03
$451.36M
derived: sum of 3 quarters · filed 2022-02-15
$596.11M
derived: sum of 4 quarters · filed 2022-02-15
2020-03-28$130.73M
10-Q · filed 2021-05-04
$462.95M
derived: sum of 2 quarters · filed 2022-02-15
$607.70M
derived: sum of 3 quarters · filed 2022-02-15
$723.76M
derived: sum of 4 quarters · filed 2022-02-15
2019-12-28$332.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15
$476.97M
derived: sum of 2 quarters · filed 2022-02-15
$593.03M
derived: sum of 3 quarters · filed 2022-02-15
$704.67M
10-K · filed 2022-02-15
2019-09-28$144.75M
10-Q · filed 2020-11-02
$260.81M
derived: sum of 2 quarters · filed 2020-11-02
$372.44M
10-Q · filed 2020-11-02
$506.62M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-29$116.06M
10-Q · filed 2020-08-04
$227.69M
10-Q · filed 2020-08-04
$361.87M
derived: sum of 3 quarters · filed 2021-02-17
$486.20M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-30$111.63M
10-Q · filed 2020-05-05
$245.81M
derived: sum of 2 quarters · filed 2021-02-17
$370.14M
derived: sum of 3 quarters · filed 2021-02-17
$511.60M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-29$134.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
$258.51M
derived: sum of 2 quarters · filed 2021-02-17
$399.97M
derived: sum of 3 quarters · filed 2021-02-17
$540.28M
10-K · filed 2021-02-17
2018-09-29$124.33M
10-Q · filed 2019-11-05
$265.79M
derived: sum of 2 quarters · filed 2019-11-05
$406.10M
10-Q · filed 2019-11-05
$397.80M
derived: sum of 4 quarters · filed 2020-02-20
2018-06-30$141.46M
10-Q · filed 2019-08-06
$281.77M
10-Q · filed 2019-08-06
$273.47M
derived: sum of 3 quarters · filed 2020-02-20
$411.76M
derived: sum of 4 quarters · filed 2020-02-20
2018-03-31$140.31M
10-Q · filed 2019-05-07
$132.01M
derived: sum of 2 quarters · filed 2020-02-20
$270.30M
derived: sum of 3 quarters · filed 2020-02-20
$406.54M
derived: sum of 4 quarters · filed 2020-02-20
2017-12-30-$8.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20
$130.00M
derived: sum of 2 quarters · filed 2020-02-20
$266.23M
derived: sum of 3 quarters · filed 2020-02-20
$407.09M
10-K · filed 2020-02-20
2017-09-30$138.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06
$274.53M
derived: sum of 2 quarters · filed 2017-11-06
$415.38M
10-Q · filed 2017-11-06
$554.95M
derived: sum of 4 quarters · filed 2019-02-20
2017-07-01$136.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08
$277.10M
10-Q · filed 2017-08-08
$416.66M
derived: sum of 3 quarters · filed 2019-02-20
$550.52M
derived: sum of 4 quarters · filed 2019-02-20
2017-04-01$140.86M
10-Q · filed 2017-05-09
$280.42M
derived: sum of 2 quarters · filed 2019-02-20
$414.28M
derived: sum of 3 quarters · filed 2019-02-20
$534.67M
derived: sum of 4 quarters · filed 2019-02-20
2016-12-31$139.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20
$273.42M
derived: sum of 2 quarters · filed 2019-02-20
$393.81M
derived: sum of 3 quarters · filed 2019-02-20
$507.63M
10-K · filed 2019-02-20
2016-09-24$133.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02
$254.25M
derived: sum of 2 quarters · filed 2016-11-02
$368.07M
10-Q · filed 2016-11-02
$498.25M
derived: sum of 4 quarters · filed 2018-02-21
2016-06-25$120.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04
$234.21M
10-Q · filed 2016-08-04
$364.39M
derived: sum of 3 quarters · filed 2018-02-21
$492.30M
derived: sum of 4 quarters · filed 2018-02-21
2016-03-26$113.83M
10-Q · filed 2016-05-03
$244.00M
derived: sum of 2 quarters · filed 2018-02-21
$371.92M
derived: sum of 3 quarters · filed 2018-02-21
$490.03M
derived: sum of 4 quarters · filed 2018-02-21
2015-12-26$130.18M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21
$258.09M
derived: sum of 2 quarters · filed 2018-02-21
$376.20M
derived: sum of 3 quarters · filed 2018-02-21
$479.84M
10-K · filed 2018-02-21
2015-09-26$127.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04
$246.03M
derived: sum of 2 quarters · filed 2015-11-04
$349.66M
10-Q · filed 2015-11-04
$482.82M
derived: sum of 4 quarters · filed 2017-02-21
2015-06-27$118.11M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29
$221.75M
10-Q · filed 2015-07-29
$354.91M
derived: sum of 3 quarters · filed 2017-02-21
$469.83M
derived: sum of 4 quarters · filed 2017-02-21
2015-03-28$103.63M
10-Q · filed 2015-05-04
$236.79M
derived: sum of 2 quarters · filed 2017-02-21
$351.72M
derived: sum of 3 quarters · filed 2017-02-21
$468.14M
derived: sum of 4 quarters · filed 2017-02-21
2014-12-27$133.16M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21
$248.09M
derived: sum of 2 quarters · filed 2017-02-21
$364.51M
derived: sum of 3 quarters · filed 2017-02-21
$466.69M
10-K · filed 2017-02-21
2014-09-27$114.93M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$231.35M
derived: sum of 2 quarters · filed 2014-11-06
$333.54M
10-Q · filed 2014-11-06
2014-06-28$116.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04
$218.61M
10-Q · filed 2014-08-04
2014-03-29$102.19M
10-Q · filed 2014-05-06
2013-12-28$432.03M
10-K · filed 2016-02-10
2012-12-29$388.58M
10-K · filed 2015-02-11
2011-12-31$368.14M
10-K · filed 2014-02-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACCENDRA HEALTH INC/VA/ (ACH)United States$0.057B-0.87